The HUMANOID Center at UC San Diego is pioneering organoid research aimed at improving the reliability and reproducibility of ...

Case reports in the literature describe acute and chronic lung impairment secondary to BHO dabbing, such as pneumonitis, pneumonia, and acute hypoxemic lung failure. Dabbing also results in ...

The signaling pathway of Activin. Image Credit: ACROBiosystems The development of medications that target Activin R opens new therapeutic options for the treatment of sarcopenia, metabolic ...

A lung biopsy involves the removal of tissue or growths from the lungs. A doctor will use special devices, such as a fine needle, to remove the sample. A lung biopsy can help diagnose lung ...

Epidermal growth factor receptor (EGFR) is a major oncogenic protein, and thus EGFR-targeting therapies are widely used in patients with various types of cancer, including lung cancer. However, ...

Disorders of surfactant protein biology cause dysfunction of alveolar type 2 cells and can lead to interstitial lung disease. This study describes the development of genetically manipulable, mature ...

In summary, we demonstrate the development of a novel alveolar organoid model and use it to identify effectors of SFTPC maturation necessary for AT2 health. Disorders of surfactant protein biology ...

There is a commercial access agreement for durvalumab. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

Additionally, continuous innovation has led to the development of next-generation ... advanced or metastatic nonsquamous non–small cell lung cancer (NSCLC). In August 2024, the FDA granted ...